TuHURA BIOSCIENCES, INC./NV Debt Issuance Cost (Deprecated 2016-01-31)
TuHURA BIOSCIENCES, INC./NV (HURA) reported Debt Issuance Cost (Deprecated 2016-01-31) of $2.74 million for the 48-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtIssuanceCosts · last filed 2014-08-28
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for the quarter ending 2013-12-31 was $0.00.
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for the quarter ending 2013-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for the quarter ending 2013-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for fiscal 2013 was $2.71M, a 10866.05% increase from fiscal 2012.
- TuHURA BIOSCIENCES, INC./NV debt issuance cost (deprecated 2016-01-31) for fiscal 2012 was $24.74K.
| Period end | Debt Issuance Cost (Deprecated 2016-01-31) 3 month | Debt Issuance Cost (Deprecated 2016-01-31) 6 month | Debt Issuance Cost (Deprecated 2016-01-31) 9 month | Debt Issuance Cost (Deprecated 2016-01-31) 12 month | Debt Issuance Cost (Deprecated 2016-01-31) 14 month | Debt Issuance Cost (Deprecated 2016-01-31) 36 month | Debt Issuance Cost (Deprecated 2016-01-31) 42 month | Debt Issuance Cost (Deprecated 2016-01-31) 45 month | Debt Issuance Cost (Deprecated 2016-01-31) 48 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $0.00 derived: 10-Q 48 month − 10-K 45 month · filed 2014-05-15 | $0.00 derived: sum of 2 quarters · filed 2014-08-28 | $0.00 derived: sum of 3 quarters · filed 2014-08-28 | $0.00 derived: sum of 4 quarters · filed 2014-08-28 | $2.74M 10-Q · filed 2014-05-15 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-28 | $0.00 derived: sum of 2 quarters · filed 2014-08-28 | $0.00 derived: sum of 3 quarters · filed 2014-08-28 | $2.71M 10-K · filed 2014-08-28 | $2.74M 10-K · filed 2014-03-10 | ||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-K 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2014-08-28 | $2.71M 10-Q · filed 2013-11-08 | $2.74M 10-Q · filed 2013-11-08 | |||||
| 2013-06-30 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2014-08-28 | $2.71M 10-K · filed 2014-08-28 | $2.74M 10-Q · filed 2013-08-12 | ||||||
| 2013-03-31 | $2.71M 10-Q · filed 2014-05-15 | $2.74M 10-Q · filed 2013-05-15 | |||||||
| 2012-12-31 | $24.74K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |